NKX6-2
protein-codingNK6 homeobox 2, the group of NKL subclass homeoboxes and pseudogenes
Gene summary
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in cell differentiation; regulation of DNA-templated transcription; and regulation of myelination. Predicted to act upstream of or within several processes, including central nervous system myelination; negative regulation of transcription by RNA polymerase II; and regulation of gliogenesis. Predicted to be located in chromatin. Predicted to be active in nucleus. Implicated in spastic ataxia 8. [provided by Alliance of Genome Resources, Jun 2026]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~3.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0033043
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0033043
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0033043
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0033043
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0033043
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NKX6-2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_177400.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 52 | 53 | |||
| missense | 3 | 2 | 101 | 3 | 109 | |
| nonsense | 4 | 3 | 7 | |||
| start loss | 0 | |||||
| frameshift | 4 | 7 | 1 | 12 | ||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 11 | 13 | 103 | 55 | 0 | 182 |
Highest pathogenic variant AF is 0.000047669604
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_796374.2 | 3 | MANE Select | |
| Ensembl | ENSP00000357581.5 | 3 | MANE Select | |
| Ensembl | ENSP00000809429.1 | 3 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| nkx6.2 | Danio rerio | Structure: primary motor neuron Quality: decreased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- negative regulation of transcription by RNA polymerase II
- regulation of transcription, DNA-templated
- negative regulation of cell fate commitment
- positive regulation of cell fate commitment
- regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification
Molecular Function
- RNA polymerase II proximal promoter sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- DNA binding
- DNA-binding transcription factor activity
Cellular Component
- nucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000368592
- Coding exons
- 3
- Length
- 1260
- Individuals with no LoFs
- 124947
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 7
- Defined
- 124954
- p
- 0.0000280
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.139 | 120 | 116 | 1.04 | 0.00000549 | 1710 |
| Missense (PolyPhen) | 53 | 48.578 | 1.091 | 575 | ||
| Synonymous | -0.196 | 57 | 55.1 | 1.03 | 0.00000278 | 593 |
| Loss of Function | 1.09 | 3 | 5.85 | 0.513 | 2.50e-7 | 86 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000028 | 0.000027 | rare |
| South Asian | 0.000034 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Transcription factor with repressor activity involved in the regulation of axon-glial interactions at myelin paranodes in oligodendrocytes. Binds to the consensus DNA sequence 5'- (A/T)TTAATGA-3'. In oligodendrocytes, binds to MBP and PLP1 promoter regions. {ECO:0000250|UniProtKB:D3Z4R4}.;
Recessive Scores
- pRec
- 0.168
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.282
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |